免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

Orbit 视网膜下给药系统

K号: K182274 · 2018-11-20

决定日期2018-11-20
产品代码FMF
咨询委员会医疗设备监管文本翻译如下: HO 请注意,由于您没有提供具体的医疗设备监管文本内容,以上仅为示例。请提供具体的文本内容以便进行准确的翻译。
决定Unknown

器械摘要

Orbit Subretinal Delivery System is the device name listed in this FDA 510(k) record. The listed applicant is Orbit Biomedical, Inc.. It received FDA 510(k) clearance on 2018-11-20 under 510(k) number K182274. The device is classified under product code FMF. It was reviewed by the HO advisory panel. FDA Decision: Unknown.

常见问题

What is the Orbit Subretinal Delivery System?

Orbit Subretinal Delivery System is a medical device that received FDA 510(k) clearance on 2018-11-20. The listed applicant is Orbit Biomedical, Inc.. The 510(k) number is K182274.

When did Orbit Subretinal Delivery System receive FDA 510(k) clearance?

Orbit Subretinal Delivery System received FDA 510(k) clearance on 2018-11-20, under 510(k) number K182274.

Who is the listed applicant for Orbit Subretinal Delivery System?

The FDA 510(k) record lists Orbit Biomedical, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Orbit Subretinal Delivery System?

The FDA product code for Orbit Subretinal Delivery System is FMF.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

相关器械(代码:FMF)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑